Skip to content
Clinical Trials – home

Prednisolone Sodium Succinate: A Comprehensive Guide for Patients

4 / 5
trials open to patients / all trials
23+
Countries

In short

This article examines the use of methylprednisolone sodium succinate, a corticosteroid medication, in clinical trials for various medical conditions. We'll explore its potential benefits, applications, and ongoing research across different areas of medicine, including respiratory disorders, autoimmune diseases, and surgical interventions.

What is Prednisolone Sodium Succinate?

Prednisolone Sodium Succinate is a type of medication known as a corticosteroid. Corticosteroids are synthetic drugs that mimic the effects of hormones naturally produced by the adrenal glands. They are powerful anti-inflammatory agents used to treat a wide range of conditions.

This medication is also known by several other names, including:

  • Methylprednisolone Sodium Succinate
  • Solu-Medrol
  • A-MethaPred
  • Medrate
  • Solu-Medrone

These alternative names may be used interchangeably in medical settings, but they all refer to the same medication.

Medical Uses

Prednisolone Sodium Succinate is used to treat a variety of medical conditions due to its potent anti-inflammatory and immunosuppressive properties. Some of the conditions it's used for include:

  • COVID-19: It's being studied for treating patients with COVID-19 pneumonia who require oxygen supplementation.
  • Graft-versus-Host Disease (GVHD): This is a complication that can occur after bone marrow transplantation. The medication is used to treat GVHD affecting the gastrointestinal tract.
  • Acute Respiratory Distress Syndrome (ARDS): This is a serious lung condition that can occur after thoracic surgery. The medication is being studied for its potential to reduce mortality in these cases.
  • Ocular (Eye) Conditions: It's used in the treatment of certain eye conditions, including those related to GVHD.

How is it Administered?

Prednisolone Sodium Succinate can be administered in several ways, depending on the condition being treated:

  • Oral tablets: For conditions like COVID-19, it may be given as oral tablets. For example, in one study, patients took 60 mg per day for 10 days.
  • Intravenous (IV) injection: For conditions like GVHD, it may be given intravenously. The dose and frequency can vary based on the specific condition and patient needs.
  • Topical application: For eye conditions, it may be formulated as eye drops. In one study, a 0.5% concentration was used twice daily.

Effectiveness

The effectiveness of Prednisolone Sodium Succinate can vary depending on the condition being treated:

  • For COVID-19, research is ongoing to determine its effectiveness compared to other corticosteroids like dexamethasone.
  • In GVHD, it has shown promise in treating gastrointestinal symptoms.
  • For ARDS after thoracic surgery, early low-dose therapy is being studied for its potential to reduce postoperative mortality.
  • In ocular conditions, it's being compared to other treatments like tacrolimus for effectiveness in treating dry eye symptoms related to GVHD.

Side Effects and Safety

Like all medications, Prednisolone Sodium Succinate can cause side effects. These can vary depending on the dosage, duration of treatment, and individual patient factors. Some potential side effects include:

  • Increased risk of infections
  • Changes in blood sugar levels
  • Changes in mood or behavior
  • Gastrointestinal issues
  • Changes in eye pressure (when used as eye drops)

It's important to note that the safety profile can differ based on how the medication is administered. For example, when used as eye drops, the risk of systemic side effects is generally lower.

Ongoing Research

Prednisolone Sodium Succinate is the subject of ongoing research to better understand its effectiveness and safety in various conditions:

  • A study is comparing it to dexamethasone for treating COVID-19 patients requiring oxygen therapy.
  • Its use in treating GVHD of the gastrointestinal tract is being studied.
  • Research is ongoing to determine if early, low-dose therapy can reduce mortality in ARDS after thoracic surgery.
  • Its effectiveness in treating ocular GVHD is being compared to other treatments.

These studies aim to provide more information about the best ways to use this medication, potentially expanding its applications in medical treatment.

Questions people often ask

Conditions where Prednisolone Sodium Succinate is being studied

Each condition opens its own overview and trial list

Trials with Prednisolone Sodium Succinate

Recruiting trials first

See all 5 →
Quick filters
  • Participants:All ages
  • Participants:All ages
  • Participants:All ages
  • Participants:Children
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.